Georgia-Pacific Names Omnicare to Improve Pharmaceutical Care for Retirees

Apr 26, 2001, 01:00 ET from Omnicare, Inc.

    COVINGTON, Ky., April 26 /PRNewswire/ -- Omnicare, Inc. (NYSE:   OCR) today
 announced that it has been selected by Georgia-Pacific Group (NYSE:   GP) to
 provide its proprietary pharmaceutical case management services for 14,000 of
 Georgia-Pacific's retirees and their dependents across the country.  Omnicare,
 the nation's leading provider of clinical pharmacy services to seniors, will
 recommend and implement pharmaceutical intervention programs to improve health
 and manage costs.
     "Because seniors often see multiple physicians, they are highly
 susceptible to medication errors and drug-related problems stemming from
 uncoordinated care," explained Joel Gemunder, President of Omnicare.  "Our
 programs with Georgia-Pacific will be designed to reduce the possibility of
 drug-related problems and their associated costs, ensuring that these retirees
 and their dependents receive the consensus 'best practices' in pharmaceutical
 care."
 
     Programs to reduce errors and improve health
     A 1999 Institute of Medicine Report, "To Err is Human," identified the
 inappropriate prescription or use of drugs as a major cause of preventable
 death.  In addition, the elderly are six times as likely to be hospitalized
 for prescription drug misadventures as the general population.  Seniors also
 may suffer more severe side effects from prescription drugs.  These side
 effects can cause confusion and unsteadiness that can lead to falls and
 fractures.
     The programs that Omnicare is developing with the Georgia-Pacific Health
 and Welfare Department will:
 
     * Work with physicians to optimize prescription drug therapy by increasing
       the use of drugs considered part of medical "best practices," beginning
       with heart failure management and prevention of a second heart attack;
 
     * Target patients taking duplicative drug therapies to reduce adverse
       health risks and costs;
 
     * Recommend that certain prescription drugs be interchanged with others
       where there is substantial evidence that they provide better clinical
       success or equal efficacy at a reduced cost; and
 
     * Reduce the number of participants who take prescription drugs that are
       considered inappropriate for use in the elderly.
 
     Improved Pharmaceutical Care Based on Scientific Guidelines
     The foundation of the Georgia-Pacific program is the Omnicare Geriatric
 Pharmaceutical Care Guidelines(R), a proprietary physician reference tool that
 was the first formulary developed specifically for improving geriatric drug
 therapies.  Now in its eighth edition, the Omnicare Guidelines(R) is
 clinically evaluated and reviewed by the Philadelphia College of Pharmacy,
 which is a nationally recognized authority on geriatric pharmaceutical care.
 In addition, it is reviewed and approved by the American Geriatrics Society.
 The Omnicare Guidelines(R) ranks nearly 850 drugs as "preferred," "acceptable"
 or "unacceptable" for treatment of seniors and the elderly in nursing
 facilities.
 
     Working with Clinicians and Georgia-Pacific Retirees
     Using Georgia-Pacific administrative, medical and prescription claims
 data, Omnicare will identify high prescription utilizers -- those most at risk
 for adverse reactions -- along with those whose current drug therapy may be
 improved.  Omnicare clinicians will then design patient-specific, therapeutic
 intervention plans and conduct outreach programs with physicians and other
 care-givers to implement these plans.
 
     Not Cost Management, but Health Management
     "We are working with Omnicare to develop these programs because of their
 geriatric expertise.  This effort will help our retirees get the prescriptions
 they need -- and protect them from prescriptions that could harm them," said
 Jody Hunter, Georgia-Pacific's Director of Health and Welfare Benefits.
 "Partnering with Omnicare to develop programs to improve pharmaceutical
 healthcare safety for our retired employees and their eligible spouses is part
 of Georgia-Pacific's effort to find new ways to improve the quality of
 healthcare as well as manage the cost."
     Mr. Gemunder said, "We are pleased to partner with Georgia-Pacific,
 because we share the same philosophy.  Both of our companies realize that the
 key to managing health care for seniors is not merely managing the unit cost
 of pharmaceuticals, but rather, managing their appropriate use.  As partners
 in this new program, Georgia-Pacific and Omnicare hope to see substantial
 improvements in both health outcomes and costs."
 
     About Georgia-Pacific
     A Fortune 100 company headquartered in Atlanta, Georgia-Pacific is one of
 the world's leading manufacturers and distributors of tissue, pulp, paper,
 packaging and building products and related chemicals, employing more than
 85,000 people at 600 locations in North America and Europe.
 
     About Omnicare
     Omnicare, Inc., based in Covington, Kentucky, is a leading geriatric
 pharmaceutical care company and clinical research organization.  Serving more
 than 636,000 residents in 8,400 long-term care facilities in 43 states,
 Omnicare is the nation's largest provider of professional pharmacy, related
 consulting and data management services for residents of long-term care
 facilities, assisted living communities and other institutional health care
 providers.  Omnicare also provides comprehensive clinical research services
 for the pharmaceutical and biotechnology industries in 23 countries worldwide.
     For more information about Omnicare, Inc., including a full menu of news
 releases, visit www.omnicare.com or prnewswire.com\com\136781.html .
 
     Statements in this press release concerning the impact the Georgia-Pacific
 contract will have on the business of Omnicare, the expected benefits of the
 program and the impact of Omnicare's clinical expertise, together with other
 statements that are not historical, are forward-looking statements that are
 estimates reflecting the best judgment of Omnicare, Inc., based on currently
 available information.  Such forward-looking statements involve known and
 unknown risks, uncertainties, contingencies and other factors that could cause
 results, performance or achievements to differ materially from those stated.
 Such risks, uncertainties, contingencies and other factors, many of which are
 beyond the control of Omnicare, Inc., include overall economic, financial and
 business conditions; trends for the continued growth in the businesses of
 Omnicare, Inc.; the impact and pace of technological advances; the ability of
 Omnicare, Inc., to obtain or maintain rights to data, technology, and other
 intellectual property and to commercialize and manufacture products; the
 effects of new government regulations, executive orders and/or legislative
 initiatives, and changes in the interpretation and application of existing
 regulation, executive orders and legislation; the failure of Omnicare, Inc.,
 to obtain or maintain required regulatory approvals or licenses; variations in
 costs or expenses; and other risks and uncertainties described in Omnicare,
 Inc.'s reports and filings with the Securities and Exchange Commission.
 
                        MAKE YOUR OPINION COUNT - Click Here
                  http://tbutton.prnewswire.com/prn/11690X53716848
 
 

SOURCE Omnicare, Inc.
    COVINGTON, Ky., April 26 /PRNewswire/ -- Omnicare, Inc. (NYSE:   OCR) today
 announced that it has been selected by Georgia-Pacific Group (NYSE:   GP) to
 provide its proprietary pharmaceutical case management services for 14,000 of
 Georgia-Pacific's retirees and their dependents across the country.  Omnicare,
 the nation's leading provider of clinical pharmacy services to seniors, will
 recommend and implement pharmaceutical intervention programs to improve health
 and manage costs.
     "Because seniors often see multiple physicians, they are highly
 susceptible to medication errors and drug-related problems stemming from
 uncoordinated care," explained Joel Gemunder, President of Omnicare.  "Our
 programs with Georgia-Pacific will be designed to reduce the possibility of
 drug-related problems and their associated costs, ensuring that these retirees
 and their dependents receive the consensus 'best practices' in pharmaceutical
 care."
 
     Programs to reduce errors and improve health
     A 1999 Institute of Medicine Report, "To Err is Human," identified the
 inappropriate prescription or use of drugs as a major cause of preventable
 death.  In addition, the elderly are six times as likely to be hospitalized
 for prescription drug misadventures as the general population.  Seniors also
 may suffer more severe side effects from prescription drugs.  These side
 effects can cause confusion and unsteadiness that can lead to falls and
 fractures.
     The programs that Omnicare is developing with the Georgia-Pacific Health
 and Welfare Department will:
 
     * Work with physicians to optimize prescription drug therapy by increasing
       the use of drugs considered part of medical "best practices," beginning
       with heart failure management and prevention of a second heart attack;
 
     * Target patients taking duplicative drug therapies to reduce adverse
       health risks and costs;
 
     * Recommend that certain prescription drugs be interchanged with others
       where there is substantial evidence that they provide better clinical
       success or equal efficacy at a reduced cost; and
 
     * Reduce the number of participants who take prescription drugs that are
       considered inappropriate for use in the elderly.
 
     Improved Pharmaceutical Care Based on Scientific Guidelines
     The foundation of the Georgia-Pacific program is the Omnicare Geriatric
 Pharmaceutical Care Guidelines(R), a proprietary physician reference tool that
 was the first formulary developed specifically for improving geriatric drug
 therapies.  Now in its eighth edition, the Omnicare Guidelines(R) is
 clinically evaluated and reviewed by the Philadelphia College of Pharmacy,
 which is a nationally recognized authority on geriatric pharmaceutical care.
 In addition, it is reviewed and approved by the American Geriatrics Society.
 The Omnicare Guidelines(R) ranks nearly 850 drugs as "preferred," "acceptable"
 or "unacceptable" for treatment of seniors and the elderly in nursing
 facilities.
 
     Working with Clinicians and Georgia-Pacific Retirees
     Using Georgia-Pacific administrative, medical and prescription claims
 data, Omnicare will identify high prescription utilizers -- those most at risk
 for adverse reactions -- along with those whose current drug therapy may be
 improved.  Omnicare clinicians will then design patient-specific, therapeutic
 intervention plans and conduct outreach programs with physicians and other
 care-givers to implement these plans.
 
     Not Cost Management, but Health Management
     "We are working with Omnicare to develop these programs because of their
 geriatric expertise.  This effort will help our retirees get the prescriptions
 they need -- and protect them from prescriptions that could harm them," said
 Jody Hunter, Georgia-Pacific's Director of Health and Welfare Benefits.
 "Partnering with Omnicare to develop programs to improve pharmaceutical
 healthcare safety for our retired employees and their eligible spouses is part
 of Georgia-Pacific's effort to find new ways to improve the quality of
 healthcare as well as manage the cost."
     Mr. Gemunder said, "We are pleased to partner with Georgia-Pacific,
 because we share the same philosophy.  Both of our companies realize that the
 key to managing health care for seniors is not merely managing the unit cost
 of pharmaceuticals, but rather, managing their appropriate use.  As partners
 in this new program, Georgia-Pacific and Omnicare hope to see substantial
 improvements in both health outcomes and costs."
 
     About Georgia-Pacific
     A Fortune 100 company headquartered in Atlanta, Georgia-Pacific is one of
 the world's leading manufacturers and distributors of tissue, pulp, paper,
 packaging and building products and related chemicals, employing more than
 85,000 people at 600 locations in North America and Europe.
 
     About Omnicare
     Omnicare, Inc., based in Covington, Kentucky, is a leading geriatric
 pharmaceutical care company and clinical research organization.  Serving more
 than 636,000 residents in 8,400 long-term care facilities in 43 states,
 Omnicare is the nation's largest provider of professional pharmacy, related
 consulting and data management services for residents of long-term care
 facilities, assisted living communities and other institutional health care
 providers.  Omnicare also provides comprehensive clinical research services
 for the pharmaceutical and biotechnology industries in 23 countries worldwide.
     For more information about Omnicare, Inc., including a full menu of news
 releases, visit www.omnicare.com or prnewswire.com\com\136781.html .
 
     Statements in this press release concerning the impact the Georgia-Pacific
 contract will have on the business of Omnicare, the expected benefits of the
 program and the impact of Omnicare's clinical expertise, together with other
 statements that are not historical, are forward-looking statements that are
 estimates reflecting the best judgment of Omnicare, Inc., based on currently
 available information.  Such forward-looking statements involve known and
 unknown risks, uncertainties, contingencies and other factors that could cause
 results, performance or achievements to differ materially from those stated.
 Such risks, uncertainties, contingencies and other factors, many of which are
 beyond the control of Omnicare, Inc., include overall economic, financial and
 business conditions; trends for the continued growth in the businesses of
 Omnicare, Inc.; the impact and pace of technological advances; the ability of
 Omnicare, Inc., to obtain or maintain rights to data, technology, and other
 intellectual property and to commercialize and manufacture products; the
 effects of new government regulations, executive orders and/or legislative
 initiatives, and changes in the interpretation and application of existing
 regulation, executive orders and legislation; the failure of Omnicare, Inc.,
 to obtain or maintain required regulatory approvals or licenses; variations in
 costs or expenses; and other risks and uncertainties described in Omnicare,
 Inc.'s reports and filings with the Securities and Exchange Commission.
 
                        MAKE YOUR OPINION COUNT - Click Here
                  http://tbutton.prnewswire.com/prn/11690X53716848
 
 SOURCE  Omnicare, Inc.

RELATED LINKS

http://www.gp.com